{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Alzheimer\u2019s disease", "bioactive compounds", "cognitive impairment", "dementia", "medicinal plants", "vascular dementia"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": [], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "33880073", "DateRevised": {"Year": "2023", "Month": "09", "Day": "19"}, "Article": {"ArticleDate": [{"Year": "2021", "Month": "04", "Day": "12"}], "Language": ["eng"], "ELocationID": ["10.2147/DNND.S299589"], "Journal": {"ISSN": "1179-9900", "JournalIssue": {"Volume": "11", "PubDate": {"Year": "2021"}}, "Title": "Degenerative neurological and neuromuscular disease", "ISOAbbreviation": "Degener Neurol Neuromuscul Dis"}, "ArticleTitle": "Bioactive Compounds and Traditional Herbal Medicine: Promising Approaches for the Treatment of Dementia.", "Pagination": {"StartPage": "1", "EndPage": "14", "MedlinePgn": "1-14"}, "Abstract": {"AbstractText": ["Dementia is a term that encompasses a group of clinical symptoms affecting memory, thinking and social abilities, characterized by progressive impairment of memory performance and cognitive functions. There are several factors involved in the pathogenesis and progression of dementia, such as old age, brain ischemia, toxin exposure, and oxidative stress. There are extensive similarities between dementia and Alzheimer's disease (AD) either in clinical manifestations or experimental animal models. AD is the most dominant form of dementia, characterized by the accumulation of beta-amyloid protein and cholinergic neurotransmission deficits in the brain. Currently available medications for the treatment of dementia, such as choline esterase inhibitors, N-methyl-D-aspartate (NMDA) antagonists (memantine), have short-term efficacy and only relieve symptoms rather than targeting the main underlying pathogenesis. Several animal studies and clinical trials are being conducted to provide a rational approach to these medicinal plants in the prevention or treatment of memory deficits. This review highlights the potential effects of medicinal plants and their derived lead molecules, and explains the related mechanisms and effects reviewed from published literature as major thrust aspects and hopeful strategies in the prevention or treatment of dementia."], "CopyrightInformation": "\u00a9 2021 Alzobaidi et al."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacology, Hamdard Institute of Medical Sciences and Research (HIMSR), Jamia Hamdard, New Delhi, India."}], "LastName": "Alzobaidi", "ForeName": "Nafaa", "Initials": "N"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Physiology, Hamdard Institute of Medical Sciences and Research (HIMSR), Jamia Hamdard, New Delhi, India."}], "LastName": "Quasimi", "ForeName": "Huma", "Initials": "H"}, {"Identifier": ["0000-0003-1852-7778"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutics, School of Pharmaceutical Education & Research, Jamia Hamdard, New Delhi, India."}], "LastName": "Emad", "ForeName": "Nasr A", "Initials": "NA"}, {"Identifier": ["0000-0001-7985-4241"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutics, College of Pharmacy, Aden University, Aden, Yemen."}], "LastName": "Alhalmi", "ForeName": "Abdulsalam", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacology, Hamdard Institute of Medical Sciences and Research (HIMSR), Jamia Hamdard, New Delhi, India."}], "LastName": "Naqvi", "ForeName": "Maaz", "Initials": "M"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "New Zealand", "MedlineTA": "Degener Neurol Neuromuscul Dis", "NlmUniqueID": "101587980", "ISSNLinking": "1179-9900"}, "CoiStatement": "The authors have declared no conflicts of interest for this work."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Chang D, Liu J, Bilinski K, et al. Herbal medicine for the treatment of vascular dementia: an overview of scientific evidence. Evid Based Compl Altern Med. 2016;2016:1\u201315. doi:10.1155/2016/7293626", "ArticleIdList": ["10.1155/2016/7293626", "PMC5223013", "28115971"]}, {"Citation": "Tewari D, Stankiewicz AM, Mocan A, Sah AN. Ethnopharmacological approaches for dementia therapy and significance of natural products and herbal drugs. Front Aging Neurosci. 2018;10(3):1\u201324. doi:10.3389/fnagi.2018.00003", "ArticleIdList": ["10.3389/fnagi.2018.00003", "PMC5816049", "29483867"]}, {"Citation": "Rossor MN, Fox NC, Mummery CJ, Schott JM, Warren JD. The diagnosis of young-onset dementia. Lancet Neurol. 2010;9(8):793\u2013806. doi:10.1016/S1474-4422(10)70159-9", "ArticleIdList": ["10.1016/S1474-4422(10)70159-9", "PMC2947856", "20650401"]}, {"Citation": "Tripathi M, Vibha D. Reversible dementias. Indian J Psychiatry. 2009;51(Suppl1):S52.", "ArticleIdList": ["PMC3038529", "21416018"]}, {"Citation": "Iadecola C. The pathobiology of vascular dementia. Neuron. 2013;80(4):844\u2013866.", "ArticleIdList": ["PMC3842016", "24267647"]}, {"Citation": "Rivas-Arancibia S, Hern\u00e1ndez-Zimbr\u00f3n LF, Rodr\u00edguez-Mart\u00ednez E, Borgonio-P\u00e9rez G, Velumani V, Dur\u00e1n-Bedolla J. Chronic exposure to low doses of ozone produces a state of oxidative stress and blood-brain barrier damage in the hippocampus of rat. Adv Biosci Biotechnol. 2013;04(11):24\u201329. doi:10.4236/abb.2013.411A2004", "ArticleIdList": ["10.4236/abb.2013.411A2004"]}, {"Citation": "Yan D, Zhang Y, Liu L, Yan H. Pesticide exposure and risk of alzheimer\u2019s disease: a systematic review and meta-analysis. Sci Rep. 2016;6(1):1\u20139. doi:10.1038/s41598-016-0001-8", "ArticleIdList": ["10.1038/s41598-016-0001-8", "PMC5007474", "27581992"]}, {"Citation": "Giri M, Zhang M, L\u00fc Y. Genes associated with alzheimer\u2019s disease: an overview and current status. Clin Interv Aging. 2016;11:665\u2013681. doi:10.2147/CIA.S105769", "ArticleIdList": ["10.2147/CIA.S105769", "PMC4876682", "27274215"]}, {"Citation": "Mecocci P, Tinarelli C, Schulz RJ, Polidori MC. Nutraceuticals in cognitive impairment and alzheimer\u2019s disease. Front Pharmacol. 2014;5 JUN(June):1\u201312.", "ArticleIdList": ["PMC4066843", "25002849"]}, {"Citation": "Van Marum RJ. Update on the use of memantine in alzheimer\u2019s disease. Neuropsychiatr Dis Treat. 2009;5(1):237\u2013247. doi:10.2147/NDT.S4048", "ArticleIdList": ["10.2147/NDT.S4048", "PMC2695219", "19557118"]}, {"Citation": "Danysz W, Parsons CG, M\u00f6bius H, St\u00f6ffler A, Quack G. Neuroprotective and symptomatological action of memantine relevant for alzheimer\u2019s disease \u2013 a unified glutamatergic hypothesis on the mechanism of action. Neurotox Res. 2000;2(2\u20133):85\u201397. doi:10.1007/BF03033787", "ArticleIdList": ["10.1007/BF03033787", "16787834"]}, {"Citation": "Guan R, Zhao Y, Zhang H, et al. Draft genome of the living fossil Ginkgo biloba. Gigascience. 2016;5(1):49. doi:10.1186/s13742-016-0154-1", "ArticleIdList": ["10.1186/s13742-016-0154-1", "PMC5118899", "27871309"]}, {"Citation": "Sun ZK, Yang HQ, Chen SD. Traditional Chinese medicine: a promising candidate for the treatment of alzheimer\u2019s disease. Transl Neurodegener. 2013;2(1):1\u20137. doi:10.1186/2047-9158-2-6", "ArticleIdList": ["10.1186/2047-9158-2-6", "PMC3599149", "23445907"]}, {"Citation": "Holstein N. Ginkgo special extract EGb 761 in tinnitus therapy. An overview of results of completed clinical trials. Fortschr Med Orig. 2001;118(4):157\u2013164.", "ArticleIdList": ["11217680"]}, {"Citation": "Schneider B. Ginkgo biloba extract in peripheral arterial diseases. Meta-analysis of controlled clinical studies. Arzneimittelforschung. 1992;42(4):428\u2013436.", "ArticleIdList": ["1386514"]}, {"Citation": "Lee EJ, Chen HY, Wu TS, Chen TY, Ayoub IA, Maynard KI. Acute administration of Ginkgo biloba extract (EGb 761) affords neuroprotection against permanent and transient focal cerebral ischemia in Sprague-Dawley rats. J Neurosci Res. 2002;68(5):636\u2013645. doi:10.1002/jnr.10251", "ArticleIdList": ["10.1002/jnr.10251", "12111854"]}, {"Citation": "Bridi R, Crossetti FP, Steffen VM, Henriques AT. The antioxidant activity of standardized extract of Ginkgo biloba (EGb 761) in rats. Phytother Res. 2001;15(5):449\u2013451. doi:10.1002/ptr.814", "ArticleIdList": ["10.1002/ptr.814", "11507743"]}, {"Citation": "Domor\u00e1kov\u00e1 I, Burda J, Mech\u00edrov\u00e1 E, Ferikov\u00e1 M. Mapping of rat hippocampal neurons with NeuN after ischemia/reperfusion and Ginkgo biloba extract (EGb 761) pretreatment. Cell Mol Neurobiol. 2006;26(7\u20138):1193\u20131204. doi:10.1007/s10571-006-9080-6", "ArticleIdList": ["10.1007/s10571-006-9080-6", "16758319"]}, {"Citation": "Kim JM, Ryou SH, Kang YH. Effect of Ginkgo biloba leaf powder and extract on plasma and liver lipids, platelet aggregation and erythrocyte Na+ efflux in rats fed hypercholesterolemic diet. FASEB J. 2011;25:S1."}, {"Citation": "Bastianetto S, Zheng WH, Quirion R. The Ginkgo biloba extract (EGb 761) protects and rescues hippocampal cells against nitric oxide-induced toxicity: involvement of its flavonoid constituents and protein kinase C. J Neurochem. 2000;74(6):2268\u20132277. doi:10.1046/j.1471-4159.2000.0742268.x", "ArticleIdList": ["10.1046/j.1471-4159.2000.0742268.x", "10820186"]}, {"Citation": "Krieglstein J, Ausmeier F, El-Abhar H, et al. Neuroprotective effects of Ginkgo biloba constituents. Eur J Pharm Sci. 1995;3(1):39\u201348. doi:10.1016/0928-0987(94)00073-9", "ArticleIdList": ["10.1016/0928-0987(94)00073-9"]}, {"Citation": "Zhang WR, Hayashi T, Kitagawa H, et al. Protective effect of Ginkgo extract on rat brain with transient middle cerebral artery occlusion. Neurol Res. 2000;22(5):517\u2013521. doi:10.1080/01616412.2000.11740713", "ArticleIdList": ["10.1080/01616412.2000.11740713", "10935227"]}, {"Citation": "Rocher MN, Carr\u00e9 D, Spinnewyn B, et al. Long-term treatment with standardized Ginkgo biloba extract (EGb 761) attenuates cognitive deficits and hippocampal neuron loss in a gerbil model of vascular dementia. Fitoterapia. 2011;82(7):1075\u20131080.", "ArticleIdList": ["21820038"]}, {"Citation": "Mohamed NES, Abd El-Moneim AE. Ginkgo biloba extract alleviates oxidative stress and some neurotransmitters changes induced by aluminum chloride in rats. Nutrition. 2017;35(93\u20139). doi:10.1016/j.nut.2016.10.012", "ArticleIdList": ["10.1016/j.nut.2016.10.012", "28241996"]}, {"Citation": "Ribeiro ML, Moreira LM, Ar\u00e7ari DP, et al. Protective effects of chronic treatment with a standardized extract of Ginkgo biloba L. in the prefrontal cortex and dorsal hippocampus of middle-aged rats. Behav Brain Res. 2016;313:144\u2013150. doi:10.1016/j.bbr.2016.06.029", "ArticleIdList": ["10.1016/j.bbr.2016.06.029", "27424157"]}, {"Citation": "Herrschaft H, Nacu A, Likhachev S, Sholomov I, Hoerr R, Schlaefke S. Ginkgo biloba extract EGb 761 \u00ae in dementia with neuropsychiatric features: a randomised, placebo-controlled trial to confirm the efficacy and safety of a daily dose of 240 mg. J Psychiatr Res. 2012;46(6):716\u2013723. doi:10.1016/j.jpsychires.2012.03.003", "ArticleIdList": ["10.1016/j.jpsychires.2012.03.003", "22459264"]}, {"Citation": "Wang M, Peng H, Peng Z, et al. Efficacy and safety of ginkgo preparation in patients with vascular dementia: a protocol for systematic review and meta-analysis. Medicine. 2020;99(37):e22209. doi:10.1097/MD.0000000000022209", "ArticleIdList": ["10.1097/MD.0000000000022209", "PMC7489658", "32925798"]}, {"Citation": "Gauthier S, Schlaefke S. Efficacy and tolerability of Ginkgo biloba extract EGb 761\u00ae in dementia: a systematic review and meta-analysis of randomized placebo-controlled trials. Clin Interv Aging. 2014;9:2065\u20132077. doi:10.2147/CIA.S72728", "ArticleIdList": ["10.2147/CIA.S72728", "PMC4259871", "25506211"]}, {"Citation": "Williamson JD, Fitzpatrick AL, Kronmal RA, et al. Ginkgo biloba for prevention of dementia. JAMA. 2008;300(19):2253\u20132262. doi:10.1001/jama.2008.683", "ArticleIdList": ["10.1001/jama.2008.683", "PMC2823569", "19017911"]}, {"Citation": "Chen F, Li L, Xu F, et al. Systemic and cerebral exposure to and pharmacokinetics of flavonols and terpene lactones after dosing standardized Ginkgo biloba leaf extracts to rats via different routes of administration. Br J Pharmacol. 2013;170(2):440\u2013457. doi:10.1111/bph.12285", "ArticleIdList": ["10.1111/bph.12285", "PMC3834766", "23808355"]}, {"Citation": "Izzo AA. Interactions between herbs and conventional drugs: overview of the clinical data. Med Princ Pract. 2012;21(5):404\u2013428. doi:10.1159/000334488", "ArticleIdList": ["10.1159/000334488", "22236736"]}, {"Citation": "Mishra LC, Singh BB, Dagenais S. Scientific basis for the therapeutic use of Withania somnifera (ashwagandha): a review. Altern Med Rev. 2000;5(4):334\u2013346.", "ArticleIdList": ["10956379"]}, {"Citation": "Farooqui AA, Farooqui T, Madan A, Ong JHJ, Ong WY. Ayurvedic medicine for the treatment of dementia: mechanistic aspects. Evid Based Compl Altern Med. 2018;2018:1\u201311. doi:10.1155/2018/2481076", "ArticleIdList": ["10.1155/2018/2481076", "PMC5976976", "29861767"]}, {"Citation": "Kuboyama T, Tohda C, Komatsu K. Withanoside IV and its active metabolite, sominone, attenuate A\u03b2(25\u201335)-induced neurodegeneration. Eur J Neurosci. 2006;23(6):1417\u20131426. doi:10.1111/j.1460-9568.2006.04664.x", "ArticleIdList": ["10.1111/j.1460-9568.2006.04664.x", "16553605"]}, {"Citation": "Chengappa KNR, Bowie CR, Schlicht PJ, Fleet D, Brar JS, Jindal R. Randomized placebo-controlled adjunctive study of an extract of Withania somnifera for cognitive dysfunction in bipolar disorder. J Clin Psychiatry. 2013;74(11):1076\u20131083. doi:10.4088/JCP.13m08413", "ArticleIdList": ["10.4088/JCP.13m08413", "24330893"]}, {"Citation": "Kim KH, Lee D, Lee HL, Kim CE, Jung K, Kang KS. Beneficial effects of panax ginseng for the treatment and prevention of neurodegenerative diseases: past findings and future directions. J Ginseng Res. 2018;42(3):239\u2013247. doi:10.1016/j.jgr.2017.03.011", "ArticleIdList": ["10.1016/j.jgr.2017.03.011", "PMC6035378", "29989012"]}, {"Citation": "Zhang G, Liu A, Zhou Y, San X, Jin T, Jin Y. Panax ginseng ginsenoside-Rg2 protects memory impairment via anti-apoptosis in a rat model with vascular dementia. J Ethnopharmacol. 2007;115(3):441\u2013448. doi:10.1016/j.jep.2007.10.026", "ArticleIdList": ["10.1016/j.jep.2007.10.026", "18083315"]}, {"Citation": "Chen F, Eckman EA, Eckman CB, Chen F, Eckman EA, Eckman CB. Reductions in levels of the alzheimer\u2019s amyloid \u03b2 peptide after oral administration of ginsenosides. FASEB J. 2006;20(8):1269\u20131271. doi:10.1096/fj.05-5530fje", "ArticleIdList": ["10.1096/fj.05-5530fje", "16636099"]}, {"Citation": "Chu S, Gu J, Feng L, et al. Ginsenoside Rg5 improves cognitive dysfunction and beta-amyloid deposition in STZ-induced memory impaired rats via attenuating neuroinflammatory responses. Int Immunopharmacol. 2014;19(2):317\u2013326. doi:10.1016/j.intimp.2014.01.018", "ArticleIdList": ["10.1016/j.intimp.2014.01.018", "24503167"]}, {"Citation": "Hur JY, Kim SS, Kim KT, et al., inventors; Korea Food Res Inst., assignee. Rg18 pharmaceutical composition for improving preventing or treating a degenerative disease comprising ginsenoside Rg18. Korean patent KR101771679 (B1). 2017 Aug 29."}, {"Citation": "Liu ZJ, Zhao M, Zhang Y, Xue JF, Chen NH. Ginsenoside Rg1 promotes glutamate release via a calcium/calmodulin-dependent protein kinase II-dependent signaling pathway. Brain Res. 2010;1333:1\u20138. doi:10.1016/j.brainres.2010.03.096", "ArticleIdList": ["10.1016/j.brainres.2010.03.096", "20381470"]}, {"Citation": "Heo JH, Lee ST, Chu K, et al. An open-label trial of Korean red ginseng as an adjuvant treatment for cognitive impairment in patients with alzheimer\u2019s disease. Eur J Neurol. 2008;15(8):865\u2013868. doi:10.1111/j.1468-1331.2008.02157.x", "ArticleIdList": ["10.1111/j.1468-1331.2008.02157.x", "18684311"]}, {"Citation": "Brondino N, Re S, Boldrini A, et al. Curcumin as a therapeutic agent in dementia: a mini systematic review of human studies. Sci World J. 2014;2014.", "ArticleIdList": ["PMC3919104", "24578620"]}, {"Citation": "Panahi Y, Hosseini MS, Khalili N, et al. Effects of curcumin on serum cytokine concentrations in subjects with metabolic syndrome: a post-hoc analysis of a randomized controlled trial. Biomed Pharmacother. 2016;82:578\u2013582. doi:10.1016/j.biopha.2016.05.037", "ArticleIdList": ["10.1016/j.biopha.2016.05.037", "27470399"]}, {"Citation": "Park SY, Kim HS, Cho EK, et al. Curcumin protected PC12 cells against beta-amyloid-induced toxicity through the inhibition of oxidative damage and tau hyperphosphorylation. Food Chem Toxicol. 2008;46(8):2881\u20132887. doi:10.1016/j.fct.2008.05.030", "ArticleIdList": ["10.1016/j.fct.2008.05.030", "18573304"]}, {"Citation": "Zhang L, Fiala M, Cashman J, et al. Curcuminoids enhance amyloid-\u03b2 uptake by macrophages of alzheimer\u2019s disease patients. J Alzheimers Dis. 2006;10(1):1\u20137. doi:10.3233/JAD-2006-10101", "ArticleIdList": ["10.3233/JAD-2006-10101", "16988474"]}, {"Citation": "Molino S, Dossena M, Buonocore D, et al. Polyphenols in dementia: from molecular basis to clinical trials. Life Sci. 2016;161:69\u201377. doi:10.1016/j.lfs.2016.07.021", "ArticleIdList": ["10.1016/j.lfs.2016.07.021", "27493077"]}, {"Citation": "Agrawal R, Mishra B, Tyagi E, Nath C, Shukla R. Effect of curcumin on brain insulin receptors and memory functions in STZ (ICV) induced dementia model of rat. Pharmacol Res. 2010;61(3):247\u2013252. doi:10.1016/j.phrs.2009.12.008", "ArticleIdList": ["10.1016/j.phrs.2009.12.008", "20026275"]}, {"Citation": "Ganguli M, Chandra V, Kamboh MI, et al. Apolipoprotein E polymorphism and alzheimer disease: the Indo-US cross-national dementia study. Arch Neurol. 2000;57(6):824\u2013830. doi:10.1001/archneur.57.6.824", "ArticleIdList": ["10.1001/archneur.57.6.824", "10867779"]}, {"Citation": "Ringman JM, Frautschy SA, Teng E, et al. Oral curcumin for alzheimer\u2019s disease: tolerability and efficacy in a 24-week randomized, double blind, placebo-controlled study. Alzheimers Res Ther. 2012;4(5):43. doi:10.1186/alzrt146", "ArticleIdList": ["10.1186/alzrt146", "PMC3580400", "23107780"]}, {"Citation": "\u00d6zt\u00fcrk M, Altay V, Hakeem KR, Ak\u00e7i\u00e7ek E. Liquorice: From Botany to Phytochemistry. Springer; 2019."}, {"Citation": "Mersereau JE, Levy N, Staub RE, et al. Liquiritigenin is a plant-derived highly selective estrogen receptor \u03b2 agonist. Mol Cell Endocrinol. 2008;283(1\u20132):49\u201357. doi:10.1016/j.mce.2007.11.020", "ArticleIdList": ["10.1016/j.mce.2007.11.020", "PMC2277338", "18177995"]}, {"Citation": "Liu RT, Zou LB, L\u00fc QJ. Liquiritigenin inhibits A\u03b225\u201335-induced neurotoxicity and secretion of A\u03b21\u201340 in rat hippocampal neurons. Acta Pharmacol Sin. 2009;30(7):899\u2013906. doi:10.1038/aps.2009.74", "ArticleIdList": ["10.1038/aps.2009.74", "PMC4006661", "19574995"]}, {"Citation": "Soo BY, Sang EP, Chung SL. Protective effect of glycyrrhizin on 1-methyl-4-phenylpyridinium-induced mitochondrial damage and cell death in differentiated PC12 cells. J Pharmacol Exp Ther. 2007;321(2):816\u2013822. doi:10.1124/jpet.107.119602", "ArticleIdList": ["10.1124/jpet.107.119602", "17314199"]}, {"Citation": "Danysz W, Parsons CG. The NMDA receptor antagonist memantine as a symptomatological and neuroprotective treatment for alzheimer\u2019s disease: preclinical evidence. Int J Geriatr Psychiatry. 2003;18(S1):S23\u2013S32. doi:10.1002/gps.938", "ArticleIdList": ["10.1002/gps.938", "12973747"]}, {"Citation": "Isemura M, Miyoshi N, Pervin M, Suzuki T, Unno K, Nakamura Y. Green tea catechins for well-being and therapy: prospects and opportunities. Bot Targets Ther. 2015;5:85\u201396. doi:10.2147/BTAT.S91784", "ArticleIdList": ["10.2147/BTAT.S91784"]}, {"Citation": "Cascella M, Bimonte S, Muzio MR, Schiavone V, Cuomo A. The efficacy of epigallocatechin-3-gallate (green tea) in the treatment of alzheimer\u2019s disease: an overview of pre-clinical studies and translational perspectives in clinical practice. Infect Agent Cancer. 2017;12(1):1\u20137. doi:10.1186/s13027-017-0145-6", "ArticleIdList": ["10.1186/s13027-017-0145-6", "PMC5477123", "28642806"]}, {"Citation": "Biasibetti R, Tramontina AC, Costa AP, et al. Green tea (-)epigallocatechin-3-gallate reverses oxidative stress and reduces acetylcholinesterase activity in a streptozotocin-induced model of dementia. Behav Brain Res. 2013;236(1):186\u2013193. doi:10.1016/j.bbr.2012.08.039", "ArticleIdList": ["10.1016/j.bbr.2012.08.039", "22964138"]}, {"Citation": "Lee YJ, Choi DY, Yun YP, Han SB, Oh KW, Hong JT. Epigallocatechin-3-gallate prevents systemic inflammation-induced memory deficiency and amyloidogenesis via its anti-neuroinflammatory properties. J Nutr Biochem. 2013;24(1):298\u2013310. doi:10.1016/j.jnutbio.2012.06.011", "ArticleIdList": ["10.1016/j.jnutbio.2012.06.011", "22959056"]}, {"Citation": "Tomata Y, Sugiyama K, Kaiho Y, et al. Green tea consumption and the risk of incident dementia in elderly Japanese: the Ohsaki Cohort 2006 Study. Am J Geriatr Psychiatry. 2016;24(10):881\u2013889. doi:10.1016/j.jagp.2016.07.009", "ArticleIdList": ["10.1016/j.jagp.2016.07.009", "27594507"]}, {"Citation": "Kim TI, Lee YK, Park SG, et al. l-Theanine, an amino acid in green tea, attenuates \u03b2-amyloid-induced cognitive dysfunction and neurotoxicity: reduction in oxidative damage and inactivation of ERK/p38 kinase and NF-\u03baB pathways. Free Radic Biol Med. 2009;47(11):1601\u20131610. doi:10.1016/j.freeradbiomed.2009.09.008", "ArticleIdList": ["10.1016/j.freeradbiomed.2009.09.008", "19766184"]}, {"Citation": "Farzaei MH, Bahramsoltani R, Abbasabadi Z, Braidy N, Nabavi SM. Role of green tea catechins in prevention of age-related cognitive decline: pharmacological targets and clinical perspective. J Cell Physiol. 2019;234(3):2447\u20132459. doi:10.1002/jcp.27289", "ArticleIdList": ["10.1002/jcp.27289", "30187490"]}, {"Citation": "Cox CJ, Choudhry F, Peacey E, et al. Dietary (-)-epicatechin as a potent inhibitor of \u03b2\u03b3-secretase amyloid precursor protein processing. Neurobiol Aging. 2015;36(1):178\u2013187. doi:10.1016/j.neurobiolaging.2014.07.032", "ArticleIdList": ["10.1016/j.neurobiolaging.2014.07.032", "PMC4270442", "25316600"]}, {"Citation": "Pervin M, Unno K, Ohishi T, Tanabe H, Miyoshi N, Nakamura Y. Beneficial effects of green tea catechins on neurodegenerative diseases. Molecules. 2018;23(6):1\u201317. doi:10.3390/molecules23061297", "ArticleIdList": ["10.3390/molecules23061297", "PMC6099654", "29843466"]}, {"Citation": "Russo A, Borrelli F. Bacopa monniera, a reputed nootropic plant: an overview. Phytomedicine. 2005;12(4):305\u2013317. doi:10.1016/j.phymed.2003.12.008", "ArticleIdList": ["10.1016/j.phymed.2003.12.008", "15898709"]}, {"Citation": "Singh HK, Dhawan BN. Drugs affecting learning and memory. Lect Neurobiol. 1992;1:189\u2013207."}, {"Citation": "Holcomb LA, Dhanasekaran M, Hitt AR, Young KA, Riggs M, Manyam BV. Bacopa monniera extract reduces amyloid levels in PSAPP mice. J Alzheimers Dis. 2006;9(3):243\u2013251. doi:10.3233/JAD-2006-9303", "ArticleIdList": ["10.3233/JAD-2006-9303", "16914834"]}, {"Citation": "Limpeanchob N, Jaipan S, Rattanakaruna S, Phrompittayarat W, Ingkaninan K. Neuroprotective effect of Bacopa monnieri on beta-amyloid-induced cell death in primary cortical culture. J Ethnopharmacol. 2008;120(1):112\u2013117. doi:10.1016/j.jep.2008.07.039", "ArticleIdList": ["10.1016/j.jep.2008.07.039", "18755259"]}, {"Citation": "Khan MB, Ahmad M, Ahmad S, et al. Bacopa monniera ameliorates cognitive impairment and neurodegeneration induced by intracerebroventricular-streptozotocin in rat: behavioral, biochemical, immunohistochemical and histopathological evidences. Metab Brain Dis. 2015;30(1):115\u2013127. doi:10.1007/s11011-014-9593-5", "ArticleIdList": ["10.1007/s11011-014-9593-5", "25037167"]}, {"Citation": "Pham HTN, Phan SV, Tran HN, et al. Bacopa monnieri (L.) ameliorates cognitive deficits caused in a trimethyltin-induced neurotoxicity model mice. Biol Pharm Bull. 2019;42(8):1384\u20131393. doi:10.1248/bpb.b19-00288", "ArticleIdList": ["10.1248/bpb.b19-00288", "31366873"]}, {"Citation": "Uabundit N, Wattanathorn J, Mucimapura S, Ingkaninan K. Cognitive enhancement and neuroprotective effects of Bacopa monnieri in alzheimer\u2019s disease model. J Ethnopharmacol. 2010;127(1):26\u201331. doi:10.1016/j.jep.2009.09.056", "ArticleIdList": ["10.1016/j.jep.2009.09.056", "19808086"]}, {"Citation": "Kamkaew N, Scholfield CN, Ingkaninan K, et al. Bacopa monnieri and its constituents is hypotensive in anaesthetized rats and vasodilator in various artery types. J Ethnopharmacol. 2011;137(1):790\u2013795. doi:10.1016/j.jep.2011.06.045", "ArticleIdList": ["10.1016/j.jep.2011.06.045", "21762768"]}, {"Citation": "Saha PS, Sarkar S, Jeyasri R, Muthuramalingam P, Ramesh M, Jha S. In vitro propagation, phytochemical and neuropharmacological profiles of Bacopa monnieri (L.) Wettst.: a review. Plants. 2020;9(4):411. doi:10.3390/plants9040411", "ArticleIdList": ["10.3390/plants9040411", "PMC7238420", "32224997"]}, {"Citation": "Kamkaew N, Norman Scholfield C, Ingkaninan K, Taepavarapruk N, Chootip K. Bacopa monnieri increases cerebral blood flow in rat independent of blood pressure. Phytother Res. 2013;27(1):135\u2013138. doi:10.1002/ptr.4685", "ArticleIdList": ["10.1002/ptr.4685", "22447676"]}, {"Citation": "Calabrese C, Gregory WL, Leo M, Kraemer D, Bone K, Oken B. Effects of a standardized Bacopa monnieri extract on cognitive performance, anxiety, and depression in the elderly: a randomized, double-blind, placebo-controlled trial. J Altern Complement Med. 2008;14(6):707\u2013713. doi:10.1089/acm.2008.0018", "ArticleIdList": ["10.1089/acm.2008.0018", "PMC3153866", "18611150"]}, {"Citation": "Kumar N, Abichandani LG, Thawani V, Gharpure KJ, Naidu MUR, Venkat Ramana G. Efficacy of standardized extract of Bacopa monnieri (Bacognize\u00ae) on cognitive functions of medical students: a six-week, randomized placebo-controlled trial. Evid Based Compl Altern Med. 2016;2016.", "ArticleIdList": ["PMC5075615", "27803728"]}, {"Citation": "Thakkar VT, Deshmukh A, Hingorani L, et al. Development and optimization of dispersible tablet of Bacopa monnieri with improved functionality for memory enhancement. J Pharm Bioallied Sci. 2017;9(3):208. doi:10.4103/jpbs.JPBS_8_17", "ArticleIdList": ["10.4103/jpbs.JPBS_8_17", "PMC5621184", "28979076"]}, {"Citation": "Sharma R, Chaturvedi C. Efficacy of Bacopa monniera in revitalizing intellectual functions in children. J Res Edu Ind Med. 1987;1:2."}, {"Citation": "Kongkeaw C, Dilokthornsakul P, Thanarangsarit P, Limpeanchob N, Norman Scholfield C. Meta-analysis of randomized controlled trials on cognitive effects of Bacopa monnieri extract. J Ethnopharmacol. 2014;151(1):528\u2013535. doi:10.1016/j.jep.2013.11.008", "ArticleIdList": ["10.1016/j.jep.2013.11.008", "24252493"]}, {"Citation": "Mitra-Ganguli T, Kalita S, Bhushan S, et al. A randomized, double-blind study assessing changes in cognitive function in Indian school children receiving a combination of Bacopa monnieri and micronutrient supplementation vs. placebo. Front Pharmacol. 2017;8(NOV):1\u201313.", "ArticleIdList": ["PMC5699204", "29204115"]}, {"Citation": "Morgan A, Stevens J. Does bacopa monnieri improve memory performance in older persons? Results of a randomized, placebo-controlled, double-blind trial. J Altern Complement Med. 2010;16(7):753\u2013759. doi:10.1089/acm.2009.0342", "ArticleIdList": ["10.1089/acm.2009.0342", "20590480"]}, {"Citation": "Joshua Allan J, Damodaran A, Deshmukh NS, Goudar KS, Amit A. Safety evaluation of a standardized phytochemical composition extracted from Bacopa monnieri in Sprague-Dawley rats. Food Chem Toxicol. 2007;45(10):1928\u20131937. doi:10.1016/j.fct.2007.04.010", "ArticleIdList": ["10.1016/j.fct.2007.04.010", "17560704"]}, {"Citation": "Sahak MKA, Kabir N, Abbas G, Draman S, Hashim NH, Hasan Adli DS. The role of Nigella sativa and its active constituents in learning and memory. Evid Based Compl Altern Med. 2016;2016.", "ArticleIdList": ["PMC4789020", "27022403"]}, {"Citation": "Ali BH, Blunden G. Pharmacological and toxicological properties of Nigella sativa. Phytother Res. 2003;17(4):299\u2013305. doi:10.1002/ptr.1309", "ArticleIdList": ["10.1002/ptr.1309", "12722128"]}, {"Citation": "Rajabian A, Hosseinzadeh H. Dermatological effects of Nigella sativa and its constituent, thymoquinone. In:\u00a0Preedy VR, Watson RR, editors. Nuts and Seeds in Health and Disease Prevention. Elsevier Inc.;2020:329\u2013355."}, {"Citation": "Azizi Z, Ebrahimi S, Saadatfar E, Kamalinejad M, Majlessi N. Cognitive-enhancing activity of thymol and carvacrol in two rat models of dementia. Behav Pharmacol. 2012;23(3):241\u2013249. doi:10.1097/FBP.0b013e3283534301", "ArticleIdList": ["10.1097/FBP.0b013e3283534301", "22470103"]}, {"Citation": "Rendeiro C, Foley A, Lau VC, et al. A role for hippocampal PSA-NCAM and NMDA-NR2B receptor function in flavonoid-induced spatial memory improvements in young rats. Neuropharmacology. 2014;79:335\u2013344. doi:10.1016/j.neuropharm.2013.12.003", "ArticleIdList": ["10.1016/j.neuropharm.2013.12.003", "PMC4062943", "24333331"]}, {"Citation": "Hosseini M, Mohammadpour T, Karami R, Rajaei Z, Reza Sadeghnia H, Soukhtanloo M. Effects of the hydro-alcoholic extract of Nigella sativa on scopolamine-induced spatial memory impairment in rats and its possible mechanism. Chin J Integr Med. 2015;21(6):438\u2013444. doi:10.1007/s11655-014-1742-5", "ArticleIdList": ["10.1007/s11655-014-1742-5", "24584756"]}, {"Citation": "Khan A, Khuwaja G, Khan MB. Effect of thymoquinone on streptozotocin model of cognitive impairment in rats. Ann Neurosci. 2008;15:94."}, {"Citation": "Alhebshi AH, Gotoh M, Suzuki I. Thymoquinone protects cultured rat primary neurons against amyloid \u03b2-induced neurotoxicity. Biochem Biophys Res Commun. 2013;433(4):362\u2013367. doi:10.1016/j.bbrc.2012.11.139", "ArticleIdList": ["10.1016/j.bbrc.2012.11.139", "23537659"]}, {"Citation": "Bin Sayeed MS, Shams T, Fahim Hossain S, et al. Nigella sativa L. seeds modulate mood, anxiety and cognition in healthy adolescent males. J Ethnopharmacol. 2014;152(1):156\u2013162. doi:10.1016/j.jep.2013.12.050", "ArticleIdList": ["10.1016/j.jep.2013.12.050", "24412554"]}, {"Citation": "Mazzanti G, Di Giacomo S. Curcumin and resveratrol in the management of cognitive disorders: what is the clinical evidence? Molecules. 2016;21(9):1\u201327. doi:10.3390/molecules21091243", "ArticleIdList": ["10.3390/molecules21091243", "PMC6273006", "27649135"]}, {"Citation": "Al-Edresi S, Alsalahat I, Freeman S, Aojula H, Penny J. Resveratrol-mediated cleavage of amyloid \u03b21\u201342 peptide: potential relevance to alzheimer\u2019s disease. Neurobiol Aging. 2020;94:24\u201333. doi:10.1016/j.neurobiolaging.2020.04.012", "ArticleIdList": ["10.1016/j.neurobiolaging.2020.04.012", "32512325"]}, {"Citation": "Rahman M, Almalki WH, Afzal O, et al. Cationic solid lipid nanoparticles of resveratrol for hepatocellular carcinoma treatment: systematic optimization, in vitro characterization and preclinical investigation. Int J Nanomedicine. 2020;15:9283\u20139299. doi:10.2147/IJN.S277545", "ArticleIdList": ["10.2147/IJN.S277545", "PMC7695602", "33262588"]}, {"Citation": "Feng Y, Wang XP, Yang SG, et al. Resveratrol inhibits beta-amyloid oligomeric cytotoxicity but does not prevent oligomer formation. Neurotoxicology. 2009;30(6):986\u2013995. doi:10.1016/j.neuro.2009.08.013", "ArticleIdList": ["10.1016/j.neuro.2009.08.013", "19744518"]}, {"Citation": "Vingtdeux V, Giliberto L, Zhao H, et al. AMP-activated protein kinase signaling activation by resveratrol modulates amyloid-\u03b2 peptide metabolism. J Biol Chem. 2010;285(12):9100\u20139113. doi:10.1074/jbc.M109.060061", "ArticleIdList": ["10.1074/jbc.M109.060061", "PMC2838330", "20080969"]}, {"Citation": "Saini RK, Rengasamy KRR, Mahomoodally FM, Keum YS. Protective effects of lycopene in cancer, cardiovascular, and neurodegenerative diseases: an update on epidemiological and mechanistic perspectives. Pharmacol Res. 2020;155(October2019):104730. doi:10.1016/j.phrs.2020.104730", "ArticleIdList": ["10.1016/j.phrs.2020.104730", "32126272"]}, {"Citation": "Alhalmi A, Beg S, Kohli K, Waris MS. Nanotechnology based approach for hepatocellular carcinoma targeting. Curr Drug Targets. 2021;22:1.", "ArticleIdList": ["33302831"]}, {"Citation": "Graff RE, Pettersson A, Lis RT, et al. Dietary lycopene intake and risk of prostate cancer defined by ERG protein expression. Am J Clin Nutr. 2016;103(3):851\u2013860. doi:10.3945/ajcn.115.118703", "ArticleIdList": ["10.3945/ajcn.115.118703", "PMC4763492", "26817504"]}, {"Citation": "Wang L, Liu S, Pradhan AD, et al. Plasma lycopene, other carotenoids, and the risk of type 2 diabetes in women. Am J Epidemiol. 2006;164(6):576\u2013585. doi:10.1093/aje/kwj240", "ArticleIdList": ["10.1093/aje/kwj240", "16801375"]}, {"Citation": "Lei X, Lei L, Zhang Z, Cheng Y. Neuroprotective effects of lycopene pretreatment on transient global cerebral ischemia-reperfusion in rats: the role of the Nrf2/HO-1 signaling pathway. Mol Med Rep. 2016;13(1):412\u2013418. doi:10.3892/mmr.2015.4534", "ArticleIdList": ["10.3892/mmr.2015.4534", "26572165"]}, {"Citation": "Zhu NW, Yin XL, Lin R, et al. Possible mechanisms of lycopene amelioration of learning and memory impairment in rats with vascular dementia. Neural Regen Res. 2020;15(2):332\u2013341. doi:10.4103/1673-5374.265565", "ArticleIdList": ["10.4103/1673-5374.265565", "PMC6905346", "31552907"]}, {"Citation": "Jiang WX, Li SH, Li XJ. Therapeutic potential of berberine against neurodegenerative diseases. Sci China Life Sci. 2015;58(6):564\u2013569. doi:10.1007/s11427-015-4829-0", "ArticleIdList": ["10.1007/s11427-015-4829-0", "PMC5823536", "25749423"]}, {"Citation": "Asai M, Iwata N, Yoshikawa A, et al. Berberine alters the processing of alzheimer\u2019s amyloid precursor protein to decrease A\u03b2 secretion. Biochem Biophys Res Commun. 2007;352(2):498\u2013502. doi:10.1016/j.bbrc.2006.11.043", "ArticleIdList": ["10.1016/j.bbrc.2006.11.043", "17125739"]}, {"Citation": "Zhao C, Su P, Lv C, et al. Berberine alleviates amyloid \u03b2 -induced mitochondrial dysfunction and synaptic loss. Oxid Med Cell Longev. 2019;2019:1\u201311. doi:10.1155/2019/7593608", "ArticleIdList": ["10.1155/2019/7593608", "PMC6525905", "31191803"]}, {"Citation": "Eskelinen MH, Kivipelto M, Cunha RA, de Mendon\u00e7a A. Caffeine as a protective factor in dementia and alzheimer\u2019s disease. J Alzheimers Dis. 2010;20(SUPPL. s1):S167\u2013S174. doi:10.3233/JAD-2010-1404", "ArticleIdList": ["10.3233/JAD-2010-1404", "20182054"]}, {"Citation": "Fredholm BB, B\u00e4ttig K, Holm\u00e9n J, Nehlig A, Zvartau EE. Actions of caffeine in the brain with special reference to factors that contribute to its widespread use. Pharmacol Rev. 1999;51(1):83\u2013133.", "ArticleIdList": ["10049999"]}, {"Citation": "Lara DR, Cunha RA, de Mendon\u00e7a A. Caffeine, mental health, and psychiatric disorders. J Alzheimers Dis. 2010;20(SUPPL. s1):S239\u2013S248. doi:10.3233/JAD-2010-1378", "ArticleIdList": ["10.3233/JAD-2010-1378", "20164571"]}, {"Citation": "Alhaider IA, Aleisa AM, Tran TT, Alzoubi KH, Alkadhi KA. Chronic-caffeine-treatment-prevents-sleep-deprivation-induced-imp-2010. Sleep. 2018;33(4):437\u2013444. doi:10.1093/sleep/33.4.437", "ArticleIdList": ["10.1093/sleep/33.4.437", "PMC2849782", "20394312"]}, {"Citation": "Duarte JMN, Carvalho RA, Cunha RA, Gruetter R. Caffeine consumption attenuates neurochemical modifications in the hippocampus of streptozotocin-induced diabetic rats. J Neurochem. 2009;111(2):368\u2013379. doi:10.1111/j.1471-4159.2009.06349.x", "ArticleIdList": ["10.1111/j.1471-4159.2009.06349.x", "19694901"]}, {"Citation": "Arendash GW, Schleif W, Rezai-Zadeh K, et al. Caffeine protects alzheimer\u2019s mice against cognitive impairment and reduces brain \u03b2-amyloid production. Neuroscience. 2006;142(4):941\u2013952. doi:10.1016/j.neuroscience.2006.07.021", "ArticleIdList": ["10.1016/j.neuroscience.2006.07.021", "16938404"]}, {"Citation": "Costa MS, Botton PH, Mioranzza S, et al. Caffeine improves adult mice performance in the object recognition task and increases BDNF and TrkB independent on phospho-CREB immunocontent in the hippocampus. Neurochem Int. 2008;53(3\u20134):89\u201394. doi:10.1016/j.neuint.2008.06.006", "ArticleIdList": ["10.1016/j.neuint.2008.06.006", "18620014"]}, {"Citation": "Qosa H, Abuznait AH, Hill RA, Kaddoumi A. Enhanced brain amyloid-\u03b2 clearance by rifampicin and caffeine as a possible protective mechanism against alzheimer\u2019s disease. J Alzheimers Dis. 2012;31(1):151\u2013165. doi:10.3233/JAD-2012-120319", "ArticleIdList": ["10.3233/JAD-2012-120319", "PMC3902015", "22504320"]}, {"Citation": "Dragicevic N, Delic V, Cao C, et al. Caffeine increases mitochondrial function and blocks melatonin signaling to mitochondria in alzheimer\u2019s mice and cells. Neuropharmacology. 2012;63(8):1368\u20131379. doi:10.1016/j.neuropharm.2012.08.018", "ArticleIdList": ["10.1016/j.neuropharm.2012.08.018", "22959965"]}, {"Citation": "Prasanthi JRP, Dasari B, Marwarha G, et al. Caffeine protects against oxidative stress and alzheimer\u2019s disease-like pathology in rabbit hippocampus induced by cholesterol-enriched diet. Free Radic Biol Med. 2010;49(7):1212\u20131220. doi:10.1016/j.freeradbiomed.2010.07.007", "ArticleIdList": ["10.1016/j.freeradbiomed.2010.07.007", "PMC2930139", "20638472"]}, {"Citation": "Eskelinen MH, Ngandu T, Tuomilehto J, Soininen H, Kivipelto M. Midlife coffee and tea drinking and the risk of late-life dementia: a population-based CAIDE study. J Alzheimers Dis. 2009;16(1):85\u201391. doi:10.3233/JAD-2009-0920", "ArticleIdList": ["10.3233/JAD-2009-0920", "19158424"]}, {"Citation": "Smith AP, Christopher G, Sutherland D. Acute effects of caffeine on attention: a comparison of non-consumers and withdrawn consumers. J Psychopharmacol. 2013;27(1):77\u201383. doi:10.1177/0269881112460112", "ArticleIdList": ["10.1177/0269881112460112", "22992376"]}, {"Citation": "Vercambre MN, Berr C, Ritchie K, Kang JH. Caffeine and cognitive decline in elderly women at high vascular risk. J Alzheimers Dis. 2013;35(2):413\u2013421. doi:10.3233/JAD-122371", "ArticleIdList": ["10.3233/JAD-122371", "PMC3807252", "23422357"]}, {"Citation": "Lindsay J, Laurin D, Verreault R, et al. Risk factors for alzheimer\u2019s disease: a prospective analysis from the Canadian Study of Health and Aging. Am J Epidemiol. 2002;156(5):445\u2013453. doi:10.1093/aje/kwf074", "ArticleIdList": ["10.1093/aje/kwf074", "12196314"]}, {"Citation": "Gelber RP, Petrovitch H, Masaki KH, Ross GW, White LR. Coffee intake in midlife and risk of dementia and its neuropathologic correlates. J Alzheimers Dis. 2011;23(4):607\u2013615. doi:10.3233/JAD-2010-101428", "ArticleIdList": ["10.3233/JAD-2010-101428", "PMC3731132", "21157028"]}, {"Citation": "Corder EH, Saunders AM, Strittmatter WJ, et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science. 1993;261(5123):921-923. doi:10.1126/science.8346443", "ArticleIdList": ["10.1126/science.8346443", "8346443"]}, {"Citation": "Van Boxtel MPJ, Schmitt JAJ, Bosma H, Jolles J. The effects of habitual caffeine use on cognitive change: a longitudinal perspective. Pharmacol Biochem Behav. 2003;75(4):921\u2013927. doi:10.1016/S0091-3057(03)00171-0", "ArticleIdList": ["10.1016/S0091-3057(03)00171-0", "12957237"]}, {"Citation": "Rho S, Kang M, Choi B, et al. Effects of Yukmijihwang-tang derivatives (YMJd), a memory enhancing herbal extract, on the gene-expression profile in the rat hippocampus. Biol Pharm Bull. 2005;28(1):87\u201393. doi:10.1248/bpb.28.87", "ArticleIdList": ["10.1248/bpb.28.87", "15635169"]}, {"Citation": "Liu JX, Cong WH, Xu L, Wang JN. Effect of combination of extracts of ginseng and ginkgo biloba on acetylcholine in amyloid beta-protein-treated rats determined by an improved HPLC. Acta Pharmacol Sin. 2004;25(9):1118\u20131123.", "ArticleIdList": ["15339385"]}, {"Citation": "Kang SY, Lee KY, Koo KA, et al. ESP-102, a standardized combined extract of Angelica gigas, Saururus chinensis and Schizandra chinensis, significantly improved scopolamine-induced memory impairment in mice. Life Sci. 2005;76(15):1691\u20131705. doi:10.1016/j.lfs.2004.07.029", "ArticleIdList": ["10.1016/j.lfs.2004.07.029", "15698848"]}], "ReferenceList": []}], "History": [{"Year": "2021", "Month": "1", "Day": "6"}, {"Year": "2021", "Month": "3", "Day": "23"}, {"Year": "2021", "Month": "4", "Day": "21", "Hour": "6", "Minute": "41"}, {"Year": "2021", "Month": "4", "Day": "22", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "4", "Day": "22", "Hour": "6", "Minute": "1"}, {"Year": "2021", "Month": "4", "Day": "12"}], "PublicationStatus": "epublish", "ArticleIdList": ["33880073", "PMC8051957", "10.2147/DNND.S299589", "299589"]}}], "PubmedBookArticle": []}